Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

PKC zeta Antikörper (N-Term)

PRKCZ Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated

Produktnummer ABIN2336399

Datenblatt (PDF)

Target Alle PKC zeta (PRKCZ) Antikörper anzeigen

PKC zeta (PRKCZ) (Protein Kinase C, zeta (PRKCZ))
Bindungsspezifität
38

30

13

10

8

5

5

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 174-203, N-Term
Reaktivität
115

63

41

9

6

5

3

3

3

2

1

1

1
Human
Wirt
126

3

1
Kaninchen
Passende Sekundärantikörper
Klonalität
117

13
Polyklonal
Konjugat
61

9

8

6

5

5

5

5

3

3

3

3

2

2

2

2

2

2

2
Dieser PKC zeta Antikörper ist unkonjugiert
Applikation
97

55

34

26

26

21

19

8

6

6

2

1

1

1

1

1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität

Human

Kreuzreaktivität (Details)

Calculated cross reactivity: Hu

Produktmerkmale

PKC zeta, NT (PRKCZ, PKC2, Protein kinase C zeta type, nPKC-zeta)

Aufreinigung

Purified by Protein G affinity chromatography.

Immunogen

PKC zeta antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 174~203 amino acids from the N-terminal region of PKC zeta.

Isotyp

IgG

Top Product

Discover our top product PRKCZ Primärantikörper
anti-Protein Kinase C, zeta (PRKCZ) (C-Term) antibody
PRKCZ Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (pThr410) antibody
PRKCZ Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (AA 165-255) antibody
PRKCZ Reaktivität: Human WB, ELISA, RNAi Wirt: Maus Monoclonal 2D1 unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (AA 453-592) antibody
PRKCZ Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (pThr560) antibody
PRKCZ Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (AA 166-197), (N-Term) antibody
PRKCZ Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB01027 unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (Cytoplasmic Domain) antibody
PRKCZ Reaktivität: Human ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (pThr410) antibody
PRKCZ Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (Thr33) antibody
PRKCZ Reaktivität: Human, Maus, Ratte, Affe WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Protein Kinase C, zeta (PRKCZ) (pThr410) antibody
PRKCZ Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

Optimal working conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Buffer

Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

-20 °C

Informationen zur Lagerung

-20°C
Target

PKC zeta (PRKCZ) (Protein Kinase C, zeta (PRKCZ))

Andere Bezeichnung

PKC zeta (PRKCZ Produkte)

Synonyme

TPKC antikoerper, PKCzeta antikoerper, prkcz-A antikoerper, pkc-zeta antikoerper, PRKCZ antikoerper, pkc2 antikoerper, PKC-ZETA antikoerper, PKC2 antikoerper, AI098070 antikoerper, C80388 antikoerper, Pkcz antikoerper, R74924 antikoerper, aPKCzeta antikoerper, zetaPKC antikoerper, 14-3-3-zetaisoform antikoerper, r14-3-3 antikoerper, pkcz antikoerper, si:ch211-150o23.4 antikoerper, protein kinase C zeta L homeolog antikoerper, protein kinase C zeta antikoerper, protein kinase C, zeta antikoerper, prkcz.L antikoerper, PRKCZ antikoerper, prkcz antikoerper, Prkcz antikoerper

UniProt

Q05513

Pathways

NF-kappaB Signalweg, RTK Signalweg, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Synaptic Membrane, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling